As the head of Eisai’s European operations, how would you assess the relevance of the European market for Eisai’s global operations when compared to the US…
In Conversation
You have been the first employee to start Dr. Reddy’s in Romania and when we look back at those early years, we see that a portfolio…
Roche is one of the oldest multinational pharmaceutical companies here in Serbia. How do you think your history in the country gives you an advantage today…
Following the acquisition of Arrow Generics by Watson in December 2009, what complementarities and synergies were generated from the transaction and where do you stand today…
Under various former names for over five decades, the Agency has undoubtedly played a key role in setting a regulatory framework for Romania’s pharmaceutical market. Over…
Pfizer is increasingly interested in emerging markets, with a focus very much on Latin America and Asia. Given this, why is Serbia exciting for Pfizer today?…
To start off, we see that you have been with Cegedim Romania for 10 years, after running your own business initially. What would you say have…
Within a broad assessment of Romania’s investment climate, there is no doubt that every country has some key factors upon which can be capitalized to attract…
You have become the head of Novo Nordisk’s operations in Romania in March 2008. Can you first give our readers an idea on how the market…
Celgene just announced very impressive second quarter results for its global operations, with a 38% increase in revenue partly led by strong growth in Europe. Within…
You have just arrived as general manager in January 2011. Coming to a new market obviously means a new context, different challenges and so on. Can…
You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD…
